Stone House Investment Management’s Teladoc Health TDOC Stock Holding History

Stone House Investment Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$644	Buy	+76	New	+$506	﹤0.01%	964

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Stone House Investment Management's TDOC Position: Q2 2026 in Review

Stone House Investment Management opened a new position in Teladoc Health (TDOC) in Q2 2026: 76 shares worth $644. The stake represents ﹤0.01% of the portfolio and ranks #964 among its holdings.

347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Stone House Investment Management held 76 shares of Teladoc Health worth $644 as of Q2 2026.
Teladoc Health was a new Stone House Investment Management position in Q2 2026.
Teladoc Health made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #964 holding.
347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.